Hydrochloric Acid

Hydrochloric Acid

SCHEMBL3935447

CO[Si](CCCNCCN)(OC)OC.Cl

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 known ✓ P00918 4/20 0.46
CHRM2 known ✓ P08172 1/20 0.33
ESR1 known ✓ P03372 1/20 0.33
CA12 O43570 5/20 0.46
CA6 P23280 5/20 0.46
CA7 P43166 5/20 0.46
CA9 Q16790 5/20 0.46
CA14 Q9ULX7 5/20 0.46
CA5B Q9Y2D0 5/20 0.46
CA4 P22748 4/20 0.46
CA5A P35218 4/20 0.46
CA3 P07451 3/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 2/20 0.43
RECQL P46063 2/20 0.43
KMT2A Q03164 2/20 0.43
UBE2N P61088 1/20 0.42
MAPT P10636 1/20 0.42
PMP22 Q01453 1/20 0.42
LMNA P02545 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL18686410 1.00 CA12 (0.46) CA12CA6CA7CA9CA14
Hydrochloric Acid SCHEMBL28525940 0.98 CA12 (0.44) CA12CA6CA7CA9CA14
SCHEMBL5891867 0.98 CA12 (0.48) CA12CA6CA7CA9CA14
SCHEMBL19549 0.98 CA12 (0.48) CA12CA6CA7CA9CA14
SCHEMBL5711364 0.98 CA12 (0.48) CA12CA6CA7CA9CA14
SCHEMBL8669640 0.96 CA12 (0.46) CA12CA6CA7CA9CA14
Ammonia Solution, Strong SCHEMBL10482257 0.96 CA12 (0.46) CA12CA6CA7CA9CA14
Ammonia Solution, Strong SCHEMBL21530853 0.96 CA12 (0.46) CA12CA6CA7CA9CA14
SCHEMBL1585330 0.96 CA12 (0.48) CA12CA6CA7CA9CA14
SCHEMBL15232333 0.96 CA12 (0.46) CA12CA6CA7CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109679581-B Composition containing 3- (N-vinylbenzyl-2-aminoethyl) aminopropyltrimethoxysilane hydrochloride and methanol 赢创运营有限公司 2022-12-16 CN disclosed
CN-114373868-A Application of compound in solar cell, solar cell and preparation method of solar cell 西安隆基乐叶光伏科技有限公司 2022-04-19 CN disclosed
CN-107531492-B Aminosilane-modified colloidal silica dispersion and method for producing same 日产化学工业株式会社 2021-03-12 CN disclosed
CN-107405287-B Mixed emulsion composition containing different emulsified particle sizes and preparation method thereof 株式会社爱茉莉太平洋 2021-01-15 CN disclosed
CN-107427442-B Chemically anisotropic powder and cosmetic composition containing the same and having stable effective material 株式会社爱茉莉太平洋 2020-08-14 CN disclosed
CN-110884240-A Cascaded phase-change cold storage box plate structure, preparation method thereof and cold storage box 东莞理工学院 2020-03-17 CN disclosed
EP-3473633-B1 COLOURLESS 3- (N-VINYLBENZYL-2-AMINOETHYL) AMINOPROPYLTRIMETHOXYSILANE HYDROCHLORIDE AND METHANOL-CONTAINING COMPOSITION, A METHOD FOR THEIR PREPARATION AND THEIR USE EVONIK DEGUSSA GMBH (DE) 2019-11-13 EP disclosed
EP-3473633-A1 COLOURLESS 3- (N-VINYLBENZYL-2-AMINOETHYL) AMINOPROPYLTRIMETHOXYSILANE HYDROCHLORIDE AND METHANOL-CONTAINING COMPOSITION, A METHOD FOR THEIR PREPARATION AND THEIR USE Evonik Degussa GmbH (DE) 2019-04-24 EP disclosed
US-7553010-B2 Phase change ink imaging component having elastomer outer layer XEROX CORPORATION (US) 2009-06-30 US disclosed
US-20070159518-A1 Phase change ink imaging component having elastomer outer layer XEROX CORPORATION 2007-07-12 US disclosed
US-7222954-B2 Phase change ink imaging component having elastomer outer layer XEROX CORPORATION (US) 2007-05-29 US disclosed
US-20050018027-A1 Phase change ink imaging component having elastomer outer layer XEROX CORPORATION 2005-01-27 US disclosed
US-20030234841-A1 Phase change ink imaging component having elastomer outer layer XEROX CORPORATION 2003-12-25 US disclosed
US-6625416-B1 Apparatus for forming images on recording medium including transfix component comprising transfix substrate having outer coating comprising haloelastomer consisting of halogenated monomers and/or polysiloxane monomers, and heating member XEROX CORPORATION 2003-09-23 US disclosed
EP-1202129-A2 Transfix component having haloelastomer outer layer Xerox Corporation (US) 2002-05-02 EP disclosed
EP-0654494-B1 Low surface energy material XEROX CORP (US) 1999-03-17 EP disclosed
US-5480938-A ELASTOMERIC UNIFORM INTEGRAL INTERPENETRATING NETWORK OF FLUOROELASTOMER-POLYORGANOSILOXANE HYBRID FORMED BY NUCLEOPHILIC DEHYDROFLUORINATION OF FLUOROELASTOMER, CATALYTIC HYDROSILATION GRAFTING OF POLYSILOXANE AT DOUBLE BOND SITES XEROX CORPORATION (US) 1996-01-02 US disclosed
EP-0654494-A1 Low surface energy material XEROX CORPORATION (US) 1995-05-24 EP disclosed